Notre Dame Researchers Create 3D Printed Blood Capillary Networks
Written with artificial intelligence.
Researchers at the University of Notre Dame have developed a method to 3D print blood capillary networks, a significant advancement in bioprinting. This breakthrough could pave the way for creating functional tissues and organs, potentially addressing the organ transplant shortage.
Importance of 3D Printed Blood Capillaries
In the United States, over 100,000 individuals are on waiting lists for organ transplants, highlighting a critical shortage of donor organs. The ability to 3D print organs using a patient's own cells could not only alleviate this scarcity but also minimize the risk of organ rejection.
The Challenge of Vascular Networks
One of the major hurdles in organ bioprinting is accurately replicating the complex vascular networks, especially the capillaries, which are essential for delivering oxygen and nutrients to cells. According to Yanliang Zhang, a professor at Notre Dame, achieving the correct scale and integrity of these vessels has proven to be a significant challenge.
Innovative Printing Techniques
To tackle this issue, the Notre Dame team combined two advanced printing techniques. The first is extrusion, used to create a soft scaffold that mimics real tissue. The second, aerosol jet printing (AJP), deposits thin gelatin threads within the scaffold, creating channels once removed. This method allows for precise adjustments in channel size, mimicking the natural variations found in human capillaries.
The researchers also incorporated machine learning to optimize printing parameters autonomously, enhancing efficiency and precision in developing the desired vascular configurations.
Future Applications
The successful creation of these networks, which can support living endothelial cells, is a major milestone. These bioprinted structures could be utilized in regenerative medicine, drug testing, and may lead to advancements in personalized medicine.
Looking ahead, Zhang aims to develop an intelligent bioprinter capable of producing fully functional organs, with new funding secured for further research in collaboration with Harvard University.